ASSESSING THE INCREASED MATERNAL AND NEONATAL HEALTH CARE COSTS ASSOCIATED WITH PREECLAMPSIA
Author(s)
Mirza Rahman, MD, MPH, Worldwide Vice President, Health Economics & Outcomes Research1, Anita Chawla, PhD, Vice President2, Leigh Ann White, PhD, Associate3, Dominic Mitchell, MS, Economist4, Eva Chang, MPH, Analyst3, Brian Gorin, MS, MBA, Managing Principal3, Douglas Woelkers, MD, Assistant Professor5, Janet Vargo, PhD, Director11Ortho Clinical Diagnostics, Raritan, NJ, USA; 2 Analysis Group, Menlo Park, CA, USA; 3 Analysis Group, Boston, MA, USA; 4 Analysis Group, Montreal, QC, Canada; 5 University of California, San Diego, San Diego, CA, USA
OBJECTIVES: To assess health care costs associated with a diagnosis of preeclampsia or hypertension during pregnancy by describing 5-month antepartum and delivery, and 3-month postpartum health care costs. METHODS: Pregnancy episodes (1999-2005) for female claimants ages 15-55 who met continuous enrollment criteria were constructed using a U.S. employer-based insurance claims database. Episodes were stratified based on a diagnosis of preeclampsia (ICD-9 642.4-642.7; N=2,435), hypertension during pregnancy (ICD-9 642.0, 642.1, 642.3, 642.9; N=2,419), or absence of either of these diagnoses (N=39,597). Pregnancy-related maternal (5-month antepartum and delivery, and 3-month postpartum) and neonatal (3-month postpartum) healthcare costs were compared using nonparametric Wilcoxon rank-sum tests, with mean values reported here. RESULTS: Antepartum and delivery costs were highest for the preeclampsia group ($13,491), followed by the hypertension ($8,899) and comparison ($8,075) groups (between-group differences p<0.001). Inpatient costs in the preeclampsia group were 58% ($11,031 vs. $6,961; p<0.001) and 63% ($11,031 vs. $6,781; p<0.001) greater than in the hypertension and comparison groups, respectively. Maternal postpartum medical costs in the preeclampsia, hypertension, and comparison groups were $1623, $1028, and $741, respectively (between-group differences p<0.001). Neonatal costs in the preeclampsia group were much higher than those in the hypertension and comparison groups ($7035 vs. $2784; p<0.001 and $7035 vs. $2484; p<0.001). More than 60% of all neonatal costs in the preeclampsia group were associated with neonatal or pediatric intensive care unit (NICU/PICU) services, compared to less than 40% in both the hypertension and comparison groups. Total maternal and neonatal postpartum costs were $8658, $3812, and $3226, respectively (between-group differences p<0.001). CONCLUSIONS: Pregnancies with a preeclampsia diagnosis are associated with significantly higher maternal antepartum and delivery costs, and all postpartum costs. Neonatal costs are also significantly higher, largely due to NICU/PICU care of babies born to mothers with a diagnosis of preeclamspia.
Conference/Value in Health Info
2008-11, ISPOR Europe 2008, Athens, Greece
Value in Health, Vol. 11, No. 6 (November 2008)
Code
PIH13
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Reproductive and Sexual Health
Explore Related HEOR by Topic